Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001610717-24-000272 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-05-31 | 2024-05-29 | IDYA | WHITE MICHAEL ANTHONY | CSO | S - Sale+OE | $36.25 | -28.5K | 0 | -100% | -$1.03M |
| DT | 2024-05-31 | 2024-05-29 | IDYA | WHITE MICHAEL ANTHONY | CSO | M - OptEx | $12.86 | +28.5K | 28.5K | New | +$366.5K |
| DT | 2024-05-31 | 2024-05-29 | IDYA | WHITE MICHAEL ANTHONY | CSO | M - OptEx | $0.00 | -28.5K | 64.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | S | D | 27,649 | $36.23 | 851 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $35.68 to $36.655, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-05-29 | M | A | 28,500 | $12.86 | 28,500 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-29 | S | D | 851 | $36.78 | 0 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $36.68 to $36.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 28,500 | $0.00 | 64,000 | D | $12.86 · — to 2032-02-29 | 28,500 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |